Activities per year
Activities
Search results
-
Gut Dysbiosis may adversely impact treatment responses with TKIs in ABL-rearranged high-risk B-ALL
Page, E. (Speaker)
29 Oct 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Metabolic vulnerabilities of myeloid neoplasm and autoimmune disease.
Hiwase, D. (Speaker)
15 Oct 2024 → 17 Oct 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
MDS Recent Updates
Hiwase, D. (Invited speaker)
17 Nov 2024 → 18 Nov 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
New Directions in Leukaemia Research (NDLR)
Eadie, L. (Speaker)
4 Mar 2024 → 6 Mar 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
When Frontline Therapy Fails
Yeung, D. (Invited speaker)
17 Oct 2024 → 18 Oct 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
CML Beyond Chronic Phase
Shanmuganathan, N. (Invited speaker)
17 Oct 2024 → 18 Oct 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
ALL-IMMUNE Study Update
White, D. (Keynote speaker)
13 Dec 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
ALL-IMMUNE Study Update
White, D. (Keynote speaker)
9 Sept 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Mesenchymal stromal cells from patients with therapy-related myeloid neoplasms exhibit a unique metabolic phenotype with defective adipocyte differentiation.
Kutyna, M. (Speaker)
15 May 2024 → 17 May 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Ph+ ALL Management - 2024
Yeung, D. (Invited speaker)
17 Oct 2024 → 18 Oct 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
CMML Diagnostics and Therapy
Thomas, D. (Invited speaker)
17 Oct 2024 → 18 Oct 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Treatment Free Remission: MRD Studies.
Pagani, I. (Invited speaker)
17 Oct 2024 → 18 Oct 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
ALL-IMMUNE Study Update
White, D. (Keynote speaker)
24 Jun 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Ph+ and Ph-like ALL: New Insights
White, D. (Invited speaker)
17 Oct 2024 → 18 Oct 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
ALL-IMMUNE Study Update
White, D. (Keynote speaker)
10 Dec 2024Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
SAHMRI Precision Cancer Medicine Theme International Women’s Day Seminar
Eadie, L. (Speaker)
8 Mar 2023Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
SAHMRI Research Showcase
Eadie, L. (Speaker)
15 Nov 2022 → 16 Nov 2022Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Blood 2022
Eadie, L. (Speaker)
11 Sept 2022 → 14 Sept 2022Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
The potential of the gut microbiota to influence immune responses to vaccination.
Lynn, D. (Speaker)
15 Jun 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Mitochondrial DNA mutations are associated with reduced OXPHOS and response to imatinib in chronic myeloid leukaemia patients. Ilaria S Pagani, Chung H Kok, Phuong Dang, Kelly Lim, Verity A Saunders, Madeleine Hughes, David T Yeung, Daniel Thomas, Timothy P Hughes, David M Ross.
Pagani, I. (Speaker)
2021 → …Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
MEK inhibitors as a targeted therapy approach to overcome resistance in Ph+ ALL cell line with PTPN11 mutations. Poudel G, Asari K, Yeung DT, White DL, Hughes TP, Pagani IS.
Pagani, I. (Speaker)
2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Update on the management of CML in 2021
Hughes, T. (Invited speaker)
Feb 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
CML Medical Expert Talk
Hughes, T. (Invited speaker)
Feb 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Society of Hematologic Oncology 2021 (SOHO)
Hughes, T. (Invited speaker)
Sept 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Novartis GET meeting
Hughes, T. (Invited speaker)
Jul 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
John Curtin School of Medical Research Seminar
White, D. (Invited speaker)
Jul 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Distinct differences between diagnosis and relapse of Ph-like acute lymphoblastic leukaemia in adolescents are revealed by single cell mRNAseq
Heatley, S. (Speaker)
20 Sept 2021 → 23 Sept 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
The gut microbiota mediates the hepatoxicity and cytokine release syndrome induced by immune agonist antibody cancer immunotherapies.
Lynn, D. (Speaker)
30 Jun 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Does the gut microbiota modulate immune responses to vaccination?
Lynn, M. (Speaker)
13 May 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Can the gut microbiota be targeted to enhance immune responses to vaccination?
Lynn, D. (Speaker)
7 Sept 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
The impact of glutamine starvation on survival and proliferation in K562 sensitive and imatinib resistant chronic myeloid leukemia cell lines. Hughes M, Saunders V, Hughes TP, Pagani IS.
Pagani, I. (Speaker)
2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Evolving Treatment Paradigm in CML: New Treatment Goals
Hughes, T. (Invited speaker)
Feb 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Heamatology Medical Gulf Summit
Hughes, T. (Invited speaker)
Feb 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Invited Speaker: RCPA: Introductory Short Course in Genetics and Molecular Pathology
White, D. (Invited speaker)
Nov 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Box Hill Haematology scientific meeting ‘EiNSTEIN’
White, D. (Invited speaker)
Apr 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Interrogating the genomic consequences of Ph-like acute lymphoblastic leukaemia in adolescents using single cell mRNAseq.
Heatley, S. (Speaker)
11 Mar 2021 → 12 Mar 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
In-vitro modelling of relapsed, refractory acute lymphoblastic leukaemia from a child with neurofibromatosis.
Heatley, S. (Speaker)
20 Sept 2021 → 23 Sept 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Australian and New Zealand Children’s Haematology/Oncology Group (ANZCHOG) Scientific Meeting
Eadie, L. (Speaker)
23 Jun 2021 → 25 Jun 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
The 5th Annual Davidoff Hematology International Conference: When Practice Meets Evidence
Hughes, T. (Invited speaker)
2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Hemo 2021 – CML / Asciminib Symposium
Hughes, T. (Invited speaker)
28 Oct 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Blood 2021
Hughes, T. (Invited speaker)
20 Sept 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Mitochondrial DNA mutations are associated with response to imatinib in chronic myeloid leukaemia patients. Pagani IS, Kok CH, Dang P, Lim K, Saunders VA, Hughes M, Kutyna MM, Hiwase DK, Yeung DT, Thomas D, Hughes TP, Ross DM.
Pagani, I. (Speaker)
2021 → …Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
19th CML Horizons 2021, Medical #2:The future of CML
Hughes, T. (Invited speaker)
22 Oct 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Drug Discovery and Development SA Symposium
White, D. (Invited speaker)
Mar 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Interrogating the genomic consequences of Ph-like acute lymphoblastic leukaemia in adolescents using single cell mRNAseq
Heatley, S. (Speaker)
22 Jun 2021 → 25 Jun 2021Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Antibiotic exposure in early life significantly alters the infant microbiota and whole blood transcriptional responses to immunisation
Ryan, F. (Speaker)
2020Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
Understanding the mechanisms of imatinib resistance in a Ph+ acute lymphoblastic leukaemia cell line. Poudel G, Yeung DT, White DL, Hughes TP, Pagani IS.
Pagani, I. (Speaker)
2020Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
COVID-19 CML insights
Hughes, T. (Speaker)
May 2020Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
The choice of treatment in CML
Hughes, T. (Invited speaker)
Jul 2020Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks
-
ABMC Research Mini-Review: Therapeutic triage and risk stratification in leukaemia: the important role of genomics
White, D. (Invited speaker)
Sept 2020Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks